Strides Pharma Science Ltd (STAR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 688428, "name": "Strides Pharma", "stock_name": "Strides Pharma", "full_name": "Strides Pharma Science Ltd", "name_url": "stocks-analysis/strides-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "997.20", "chg": 26.8, "chgp": "2.76%", "dir": 1, "prev_price": "970.40", "mcapval": "8,909.00 Cr", "mcap": "Small Cap", "scripcode": 532531, "symbol": "STAR", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE939A01011", "curr_date": "Aug 06, 03:30 PM", "curr_time": "21:46 PM", "last_traded_at": "Aug 06, 03:30 PM IST", "bse_nse_vol": "4.38 lacs", "exc_status": "Active", "traded_date": "Aug 06, 2026", "traded_date_str": "2026 08 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-technical-momentum-shifts-amid-mixed-market-signals-4137006", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_technicaldot_4137006.png", "date": "2026-08-05 08:04:11", "description": "Strides Pharma Science Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of bearish and bullish signals across key technical indicators. Despite a recent downgrade in daily price performance, the stock’s year-to-date and longer-term returns continue to outpace the broader Sensex, underscoring its resilience amid sectoral and market fluctuations." }, { "title": "Strides Pharma Science Ltd Shows Mixed Technical Signals Amid Mildly Bullish Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-shows-mixed-technical-signals-amid-mildly-bullish-momentum-4134841", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_technicaldot_4134841.png", "date": "2026-08-04 08:06:21", "description": "Strides Pharma Science Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors amid a volatile pharmaceutical sector backdrop." }, { "title": "Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4132905", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_technicaldot_4132905.png", "date": "2026-08-03 08:01:56", "description": "Strides Pharma Science Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price momentum, the stock’s longer-term outlook remains cautiously optimistic, supported by strong year-to-date returns and a recent upgrade in its Mojo Grade from Sell to Hold." }, { "title": "Strides Pharma Science Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-valuation-shifts-signal-renewed-price-attractiveness-4132809", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_valuationdot_4132809.png", "date": "2026-08-03 08:00:41", "description": "Strides Pharma Science Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent 4.67% decline in its share price. This re-rating comes amid a challenging Pharmaceuticals & Biotechnology sector landscape, where Strides’ valuation metrics now stand out favourably against peers and historical averages, signalling potential value for investors." }, { "title": "Strides Pharma Science Ltd Reports Positive Quarterly Performance Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-reports-positive-quarterly-performance-amid-market-volatility-4132749", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_fintrenddot_4132749.png", "date": "2026-08-03 08:00:11", "description": "Strides Pharma Science Ltd has delivered a positive quarterly performance for June 2026, reflecting a shift from a previously very positive to a positive financial trend. Despite a recent downgrade in its Mojo Score from 20 to 10 over the past three months, the company continues to demonstrate robust operational cash flows and improved profitability metrics, signalling resilience in a challenging market environment." }, { "title": "Strides Pharma Science Ltd Quality Grade Upgrade Reflects Mixed Fundamental Trends", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-quality-grade-upgrade-reflects-mixed-fundamental-trends-4132736", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/StridesPharmaSc_qualitydot_4132736.png", "date": "2026-08-03 08:00:09", "description": "Strides Pharma Science Ltd has seen its quality grade upgraded from below average to average, reflecting notable improvements in its business fundamentals. This shift is underpinned by stronger profitability metrics, manageable debt levels, and enhanced operational efficiency, positioning the small-cap pharmaceutical player more favourably within its sector." }, { "title": "Strides Pharma Gains 0.42%: 4 Key Factors Driving the Week’s Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-gains-042-4-key-factors-driving-the-weeks-mixed-momentum-4131775", "imagepath": "", "date": "2026-08-01 16:04:56", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> Valuation shifts to very attractive amid sector challenges</p>\n <p><strong>28 Jul:</strong> Upgraded to Hold by MarketsMOJO on improved technicals and valuation</p>\n <p><strong>28 Jul:</strong> Technical momentum shifts amid mixed indicator signals</p>\n <p><strong>31 Jul:</strong> Q1 FY27 results show strong profit surge but margin concerns</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,019.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Cl..." }, { "title": "Strides Pharma Q1 FY27: Strong Profit Surge Masks Operating Margin Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/strides-pharma-q1-fy27-strong-profit-surge-masks-operating-margin-concerns-4130718", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/StridesPharmaSc_quaterlyResult_4130718.png", "date": "2026-07-31 19:02:11", "description": "Strides Pharma Science Ltd. reported a robust 57.52% year-on-year surge in consolidated net profit to ₹156.91 crores for Q1 FY27, driven by strong sales momentum and improved operational efficiency. However, the stock tumbled 4.67% following the results announcement, closing at ₹1,023.25, as investors reacted to sequential margin compression and concerns over sustainability of growth." }, { "title": "Strides Pharma Science Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation", "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-valuation-4123596", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/StridesPharmaSc_mojoScore_4123596.png", "date": "2026-07-28 08:26:22", "description": "Strides Pharma Science Ltd has seen its investment rating upgraded from Sell to Hold, reflecting notable improvements in technical indicators and valuation metrics. The upgrade, effective from 27 July 2026, is underpinned by a shift to a mildly bullish technical trend, an attractive valuation profile, and strong recent financial performance, despite some lingering concerns over long-term fundamentals and promoter share pledging." } ], "total": 718, "sid": "688428", "stock_news_url": "https://www.marketsmojo.com/news/strides-pharma-science-688428" }, "announcements": [ { "details": "Strides Pharma Science Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Strides Pharma Science Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "05-Dec-2019" }, { "details": "Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.", "source": "NSE", "caption": "Strides Pharma Science Limited - Shareholders meeting", "datetime": "26-Nov-2019" }, { "details": "Strides Pharma Science Limited has informed the Exchange regarding a press release dated November 08, 2019, titled \"Strides announces relaunch of Ranitidine tablets (Rx) for the US Market\".", "source": "NSE", "caption": "Strides Pharma Science Limited - Press Release", "datetime": "08-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Strides Pharma Science Ltd has declared <strong>50%</strong> dividend, ex-date: 31 Jul 26", "dt": "2026-07-31", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Jul: Valuation shifts to very attractive amid sector challenges

28 Jul: Upgraded to Hold by MarketsMOJO on improved technicals and valuation

28 Jul: Technical momentum shifts amid mixed indicator signals

31 Jul: Q1 FY27 results show strong profit surge but margin concerns

Week Open

Rs.1,019.00

Week Cl...

Read full news article

Strides Pharma Q1 FY27: Strong Profit Surge Masks Operating Margin Concerns

2026-07-31 19:02:11

Strides Pharma Science Ltd. reported a robust 57.52% year-on-year surge in consolidated net profit to ₹156.91 crores for Q1 FY27, driven by strong sales momentum and improved operational efficiency. However, the stock tumbled 4.67% following the results announcement, closing at ₹1,023.25, as investors reacted to sequential margin compression and concerns over sustainability of growth.

Read full news article

Strides Pharma Science Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation

2026-07-28 08:26:22

Strides Pharma Science Ltd has seen its investment rating upgraded from Sell to Hold, reflecting notable improvements in technical indicators and valuation metrics. The upgrade, effective from 27 July 2026, is underpinned by a shift to a mildly bullish technical trend, an attractive valuation profile, and strong recent financial performance, despite some lingering concerns over long-term fundamentals and promoter share pledging.

Read full news article